DRAP promotes importing medicinal raw materials using Chinese currency.
In order to ensure the availability of important medications in the face of a dollar liquidity crisis, the Drug Regulatory Authority of Pakistan's (DRAP) Drug Availability Committee has suggested importing medical raw materials and equipment from China in its currency, the RMB (Yuan).
"As the LCs issue is hampering the import of active pharmaceutical ingredient (API) from China and India, the Drug Availability Committee of DRAP has come up with a solution to import the medicines' raw material from China in its local currency RMB (Yuan) to ensure availability of essential medicines in the country," DRAP Chief Executive Officer (CEO) Asim Rauf said at a meeting with leaders of the local pharmaceutical industry today in Karachi.
The News said that pharmaceutical businesses are having trouble importing completed goods and raw ingredients.
Comments
Post a Comment